These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35931008)

  • 1. MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis.
    Aloisi F; Cross AH
    J Neuroimmunol; 2022 Oct; 371():577935. PubMed ID: 35931008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.
    Veroni C; Aloisi F
    Front Immunol; 2021; 12():665718. PubMed ID: 34305896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
    Otto C; Hofmann J; Ruprecht K
    Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
    Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J
    J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and multiple sclerosis.
    Soldan SS; Lieberman PM
    Nat Rev Microbiol; 2023 Jan; 21(1):51-64. PubMed ID: 35931816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection.
    Hedström AK
    Front Immunol; 2023; 14():1212676. PubMed ID: 37554326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Epstein-Barr virus latently expressed genes with multiple sclerosis.
    Varvatsi D; Richter J; Tryfonos C; Pantzaris M; Christodoulou C
    Mult Scler Relat Disord; 2021 Jul; 52():103008. PubMed ID: 34010765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
    Sargsyan SA; Shearer AJ; Ritchie AM; Burgoon MP; Anderson S; Hemmer B; Stadelmann C; Gattenlöhner S; Owens GP; Gilden D; Bennett JL
    Neurology; 2010 Apr; 74(14):1127-35. PubMed ID: 20220124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.
    Meier UC; Cipian RC; Karimi A; Ramasamy R; Middeldorp JM
    Front Immunol; 2021; 12():757302. PubMed ID: 34790199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-barr virus infection and multiple sclerosis: a review.
    Ascherio A; Munger KL
    J Neuroimmune Pharmacol; 2010 Sep; 5(3):271-7. PubMed ID: 20369303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus and multiple sclerosis.
    Salvetti M; Giovannoni G; Aloisi F
    Curr Opin Neurol; 2009 Jun; 22(3):201-6. PubMed ID: 19359987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unleashing the power of anti-CD20 immunotherapy: Mitigating multiple sclerosis risk in Epstein-Barr virus latent infections.
    Alrashoudi RH
    Adv Clin Exp Med; 2024 Aug; 33(8):869-880. PubMed ID: 38085006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.
    Ruprecht K
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255
    [No Abstract]   [Full Text] [Related]  

  • 15. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.
    Willis SN; Stadelmann C; Rodig SJ; Caron T; Gattenloehner S; Mallozzi SS; Roughan JE; Almendinger SE; Blewett MM; Brück W; Hafler DA; O'Connor KC
    Brain; 2009 Dec; 132(Pt 12):3318-28. PubMed ID: 19638446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher frequency of Human herpesvirus-6 (HHV-6) viral DNA simultaneously with low frequency of Epstein-Barr virus (EBV) viral DNA in a cohort of multiple sclerosis patients from Rio de Janeiro, Brazil.
    Pereira JG; Leon LAA; de Almeida NAA; Raposo-Vedovi JV; Fontes-Dantas FL; Farinhas JGD; Pereira VCSR; Alves-Leon SV; de Paula VS
    Mult Scler Relat Disord; 2023 Aug; 76():104747. PubMed ID: 37267685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Immune Response to the Epstein-Barr Virus as a Prerequisite for Multiple Sclerosis.
    Läderach F; Münz C
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Epstein-Barr virus in multiple sclerosis: when and how?
    Giovannoni G
    Curr Opin Neurol; 2024 Jun; 37(3):228-236. PubMed ID: 38511407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis.
    Veroni C; Serafini B; Rosicarelli B; Fagnani C; Aloisi F
    J Neuroinflammation; 2018 Jan; 15(1):18. PubMed ID: 29338732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.
    Owens GP; Bennett JL
    Mult Scler; 2012 Sep; 18(9):1204-8. PubMed ID: 22685062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.